Ardelyx Inc (NAS:ARDX)
$ 5.72 -0.17 (-2.89%) Market Cap: 1.35 Bil Enterprise Value: 1.31 Bil PE Ratio: 0 PB Ratio: 8.54 GF Score: 79/100

Ardelyx Inc Corporate Analyst Meeting Transcript

Oct 17, 2019 / 12:00PM GMT
Release Date Price: $4.63 (+6.68%)
Michael G. Raab
Ardelyx, Inc. - President, CEO & Director

Well, good morning. Thank you for joining us at our Second Analyst Day -- Investor Day for Ardelyx. One of the things that we've gotten a lot of questions on when we've been speaking to each of you is how does this look like when we commercialize this? What does this market look like? A question that just got again this morning that we will try to provide some more perspective on is the bundle, where we fit in the complicated peculiar but we think very interesting and approachable reimbursement world that we deal with, with dialysis patients.

Obviously, this has been a remarkable year for us. Obviously, I'm going to be making forward-looking statements. Sorry, Liz. I should have said that earlier. And our objective is it's a mission for us to enhance the lives of patients that are on dialysis. This is a population of people that doesn't get the attention that you would normally expect people that are as sick as this need to get. It is somewhat a group of people that we focus on and most of us have for a big portion of our careers.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot